Learn more about Elsevier’s Drug Patient Education today! Empower and engage your patients to use medication safely.
EMICIZUMAB (em i SIZ ue mab) prevents or reduces how often bleeding episodes occur in people with hemophilia A. It works by helping your body make factor VIII, a protein that helps your blood clot. This lowers the risk of bleeding. It is a monoclonal antibody.
This medication is injected under the skin. You will be taught how to prepare and give it. Take it as directed on the prescription label at the same time every day. Keep taking it unless your care team tells you to stop.
It is important that you put your used needles and syringes in a special sharps container. Do not put them in a trash can. If you do not have a sharps container, call your pharmacist or care team to get one.
A special MedGuide will be given to you by the pharmacist with each prescription and refill. Be sure to read this information carefully each time.
Talk to your care team about the use of this medication in children. While it may be prescribed for children for selected conditions, precautions do apply.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Keep out of the reach of children and pets.
If you are using this medication at home, you will be instructed on how to store it. Get rid of any unused medication after the expiration date.
To get rid of medications that are no longer needed or have expired:
They need to know if you have any of these conditions:
If you miss a dose, take it as soon as you can. If it is almost time for your next dose, take only that dose. Do not take double or extra doses.
Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse. You may need blood work done while you are taking this medication.
Cookies are used by this site. To decline or learn more, visit our cookie notice.